Article info

Download PDFPDF

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program
Free

Authors

  1. a Roxanne.Payne{at}Providence.org
  2. b Lyn.Glenn{at}Providence.org
  3. c Helena.Hoen{at}Providence.org
  4. d Beverley.Richards{at}Providence.org
  5. e John.Smith{at}usoncology.com
  6. f Robert.Lufkin{at}usoncology.com
  7. g Todd.Crocenzi{at}Providence.org
  8. h Walter.Urba{at}Providence.org
  9. i Brendan.Curti{at}Providence.org
View Full Text

Citation

Payne R, Glenn L, Hoen H, et al
Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program

Publication history

  • Received January 29, 2014
  • Accepted April 22, 2014
  • First published May 14, 2014.
Online issue publication 
May 14, 2014

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.